Moon, H.H.; Ike, C.; Dixon, R.W.; Crowe, C.L.; Venkataraman, M.; Morris, V.; Kearney, M.; Tonnu-Mihara, I.; Barron, J.
Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study. Curr. Oncol. 2025, 32, 384.
https://doi.org/10.3390/curroncol32070384
AMA Style
Moon HH, Ike C, Dixon RW, Crowe CL, Venkataraman M, Morris V, Kearney M, Tonnu-Mihara I, Barron J.
Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study. Current Oncology. 2025; 32(7):384.
https://doi.org/10.3390/curroncol32070384
Chicago/Turabian Style
Moon, Helen H., Chiemeka Ike, Ruth W. Dixon, Christopher L. Crowe, Malvika Venkataraman, Valerie Morris, Mairead Kearney, Ivy Tonnu-Mihara, and John Barron.
2025. "Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study" Current Oncology 32, no. 7: 384.
https://doi.org/10.3390/curroncol32070384
APA Style
Moon, H. H., Ike, C., Dixon, R. W., Crowe, C. L., Venkataraman, M., Morris, V., Kearney, M., Tonnu-Mihara, I., & Barron, J.
(2025). Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study. Current Oncology, 32(7), 384.
https://doi.org/10.3390/curroncol32070384
